Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic medicine is accelerating in Japan.
Hayashi S, Kubo M, Kaneshiro K, Kai M, Yamada M, Morisaki T, Takao Y, Shimazaki A, Shikada S, Nakamura M. Hayashi S, et al. Among authors: kaneshiro k. Breast Cancer. 2022 Jul;29(4):659-665. doi: 10.1007/s12282-022-01342-4. Epub 2022 Feb 21. Breast Cancer. 2022. PMID: 35191009 Free PMC article.
T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.
Mori H, Kubo M, Kai M, Yamada M, Kurata K, Kawaji H, Kaneshiro K, Osako T, Nishimura R, Arima N, Okido M, Kishimoto J, Oda Y, Nakamura M. Mori H, et al. Among authors: kaneshiro k. Breast Cancer Res Treat. 2019 Aug;176(3):569-577. doi: 10.1007/s10549-019-05256-2. Epub 2019 May 8. Breast Cancer Res Treat. 2019. PMID: 31069590 Free PMC article.
Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H, Kubo M, Yamashita N, Yamamoto H, Kai M, Kajihara A, Yamada M, Kurata K, Kaneshiro K, Harada Y, Hayashi S, Shimazaki A, Mori H, Akiyoshi S, Oki E, Oda Y, Baba E, Mori M, Nakamura M. Kawaji H, et al. Among authors: kaneshiro k. Cancer Med. 2021 Jan;10(2):529-539. doi: 10.1002/cam4.3619. Epub 2020 Dec 4. Cancer Med. 2021. PMID: 33274848 Free PMC article.
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.
Zaguirre K, Kai M, Kubo M, Yamada M, Kurata K, Kawaji H, Kaneshiro K, Harada Y, Hayashi S, Shimazaki A, Morisaki T, Mori H, Oda Y, Chen S, Moriyama T, Shimizu S, Nakamura M. Zaguirre K, et al. Among authors: kaneshiro k. Cancer Med. 2021 Mar;10(5):1605-1613. doi: 10.1002/cam4.3713. Epub 2021 Jan 15. Cancer Med. 2021. PMID: 33452761 Free PMC article.
Current Status and Problems of Breast Cancer Treatment with Schizophrenia.
Kaneshiro K, Kubo M, Taniguchi M, Yamada M, Sadakari Y, Kai M, Tsutsumi C, Tsukamoto T, Yoshida N, Tanaka M, Ogata T, Nakamura M. Kaneshiro K, et al. Clin Breast Cancer. 2022 Jun;22(4):e399-e406. doi: 10.1016/j.clbc.2021.10.006. Epub 2021 Nov 4. Clin Breast Cancer. 2022. PMID: 34862143 Free article.
Significance of the Multi-gene Panel myRisk in Japan.
Hayashi S, Kubo M, Matsuzaki S, Kai M, Morisaki T, Yamada M, Kaneshiro K, Takao Y, Shimazaki A, Nagayoshi K, Mizuuchi Y, Nakamura M. Hayashi S, et al. Among authors: kaneshiro k. Anticancer Res. 2022 Aug;42(8):4097-4102. doi: 10.21873/anticanres.15907. Anticancer Res. 2022. PMID: 35896222
101 results